Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD105 (Endoglin) as negative prognostic factor in AML

4 Dec 2019

Abstract excerpt

Abstract While several genetic and morphological markers are established and serve to guide therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional markers to better stratify patients. CD105 (Endoglin) is a type I transmembrane protein reported to induce activation and proliferation of endothelial cells. In addition, CD105 is expressed in haematological malignancies and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Immune cells in cancer
Share to Neutrophil, Myeloperoxidase and Oxidative Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31797971
DOI: 10.1038/s41598-019-54767-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD105 (Endoglin) as negative prognostic factor in AMLPMID 31797971Read ↗

Endoglin: An accessory component of the TGF‐β‐binding receptor‐complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignanciesSemantic proximity Read ↗

CD105 is important for angiogenesis: evidence and potential applications.Semantic proximity Read ↗

ITGAL infers adverse prognosis and correlates with immunity in acute myeloid leukemiaSemantic proximity Read ↗

Functional integration of acute myeloid leukemia into the vascular niche.Semantic proximity Read ↗

Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia.Semantic proximity Read ↗

High levels of immunoglobulin expression predict shorter overall survival in patients with acute myeloid leukemia.Semantic proximity Read ↗

CD304 is preferentially expressed on a subset of B‐lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometrySemantic proximity Read ↗

VEGFR-1 (FLT-1), β1 integrin, and hERG K+ channel for a macromolecular signaling complex in acute myeloid leukemia: role in cell migration and clinical outcomeSemantic proximity Read ↗

Prognostic relevance of angiopoietin-2, fibroblast growth factor-2 and endoglin mRNA expressions in chronic lymphocytic leukemia.Semantic proximity Read ↗

Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer.Semantic proximity Read ↗

Endoglin expression is associated with poor oncologic outcome in oral and oropharyngeal carcinomaSemantic proximity Read ↗

Characterization of Siglec-5, a Novel Glycoprotein Expressed on Myeloid Cells Related to CD33Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.